000 | 01877 a2200529 4500 | ||
---|---|---|---|
005 | 20250517185510.0 | ||
264 | 0 | _c20180327 | |
008 | 201803s 0 0 rus d | ||
022 | _a0040-3660 | ||
024 | 7 |
_a10.17116/terarkh2017891017-21 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBolotskaya, L L | |
245 | 0 | 0 |
_a[A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory]. _h[electronic resource] |
260 |
_bTerapevticheskii arkhiv _c |
||
300 |
_a17-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge of Onset |
650 | 0 | 4 |
_aAlbuminuria _xdiagnosis |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
650 | 0 | 4 |
_aDiabetic Nephropathies _xdiagnosis |
650 | 0 | 4 |
_aDiabetic Retinopathy _xdiagnosis |
650 | 0 | 4 |
_aDiagnostic Techniques, Ophthalmological _xstatistics & numerical data |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
650 | 0 | 4 |
_aInsulin _xtherapeutic use |
650 | 0 | 4 |
_aKidney Function Tests _xstatistics & numerical data |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aRussia _xepidemiology |
700 | 1 | _aBessmertnaya, E G | |
700 | 1 | _aShestakova, M V | |
700 | 1 | _aShamkhalova, M Sh | |
700 | 1 | _aNikankina, L V | |
700 | 1 | _aIlyin, A V | |
700 | 1 | _aGlek, I S | |
700 | 1 | _aZolotukhin, A V | |
700 | 1 | _aDedov, I I | |
773 | 0 |
_tTerapevticheskii arkhiv _gvol. 89 _gno. 10 _gp. 17-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.17116/terarkh2017891017-21 _zAvailable from publisher's website |
999 |
_c27821237 _d27821237 |